Change to the information provided on adverse events in the Summary of Product Characteristics (SPC).
Following monitoring of pharmacovigilance data, the Summary of Product Characteristics (SPC) for DIVENCE PENTA lyophilisate and solvent for emulsion for injection has been updated:
A temporary mild reduction in milk production, feed intake and activity may uncommonly be observed in dairy cows, mostly after the first dose.
No medicine is 100% risk free, the SPC includes information on what adverse events have been known to occur following administration of a particular product, these can be found in either section Adverse events (3.6) or Adverse reactions (4.6).
Any veterinary medicinal product which is authorised for marketing in the United Kingdom will have its Summary of Product Characteristics (SPC) available on our Product Information Database .
All updates to SPCs other than template changes, are published in the medicine updates section of VMD Connect .
